<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01593501</url>
  </required_header>
  <id_info>
    <org_study_id>HSC #2011-0547</org_study_id>
    <secondary_id>R01AG028739-01A2</secondary_id>
    <nct_id>NCT01593501</nct_id>
  </id_info>
  <brief_title>How Does Magnesium Status Influence Calcium Homeostasis?</brief_title>
  <official_title>How Does Magnesium Status Influence Calcium Homeostasis?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators aim to recruit 60 women who have agreed to participate in an existing
      randomized, double-blind, placebo-controlled trial (Treatment of Vitamin D Insufficiency, HSC
      2009-0055). In this trial, the investigators propose to evaluate the associations between
      magnesium intake, magnesium stores, fractional magnesium absorption and calcium homeostasis.
      The investigators will stratify 60 subjects in the sub-study, ensuring that approximately 20
      subjects are randomized into each treatment arm (placebo, low-dose and high-dose vitamin D).
      The investigators already assess calcium homeostasis throughout the study by measuring bone
      mineral density, fractional calcium absorption, serum and urine calcium levels, among other
      tests. In the sub-study of 60 women, the investigators will evaluate whether habitually
      higher magnesium intake increases or decreases fractional calcium absorption. The
      investigators will evaluate the interplay between magnesium stores, vitamin D levels and
      serum parathyroid hormone levels. The investigators will directly assess magnesium stores
      using serum magnesium and 24-hour urine magnesium levels, and will measure magnesium
      absorption using the dual stable isotope approach.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Use of serum magnesium isotopes to measure fractional magnesium absorption Four day food
      diaries to assess magnesium intake Standard urine and serum chemistries for remaining labs as
      noted above
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2012</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluate the associations between magnesium intake, magnesium stores, fractional magnesium absorption and calcium homeostasis.</measure>
    <time_frame>0-12 months</time_frame>
    <description>To evaluate relationships between magnesium intake and fractional magnesium absorption at baseline and 12 months, among 60 women participating in HSC Protocol 2009-0055, and to assess whether vitamin D therapy influences magnesium absorption among these women. We will also evaluate whether data collected from less than 72 hours of urine following tracer administration permits accurate assessment of fractional magnesium absorption.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Does vitamin D therapy have a differential impact on calcium absorption that is dependent on magnesium stores?</measure>
    <time_frame>0-12 months</time_frame>
    <description>To assess whether vitamin D therapy has a differential impact on calcium absorption, depending on magnesium stores. We will use data from all subjects participating in HSC Protocol 2009-0055 to evaluate whether magnesium status is a co-factor in the change in calcium absorption that occurs with vitamin D therapy.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assessing relationships between magnesium status and bone mineral density.</measure>
    <time_frame>0-12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate how magnesium status impacts the relationship between vitamin D levels and parathyroid hormone levels.</measure>
    <time_frame>0-12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">39</enrollment>
  <condition>Magnesium Deficiency</condition>
  <condition>Calcium Metabolism Disorders</condition>
  <arm_group>
    <arm_group_label>High dose vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>50,000 IU vitamin D3 every 15 days, with a loading dose of 50,000 IU per day for the first 15 days of an approximate 365-day treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Low dose vitamin D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>800 IU vitamin D3 every day of an approximate 365-day treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A pill that looks like the low/high dose vitamin D pills, but contains no vitamin D. Given to preserve the double-blind nature of the study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>vitamin D3</intervention_name>
    <description>pharmaceutical grade D3</description>
    <arm_group_label>High dose vitamin D</arm_group_label>
    <arm_group_label>Low dose vitamin D</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Cholecalciferol</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  participants eligible for the study &quot;Treatment of vitamin D insufficiency&quot; are
             eligible for participation in the current sub-study

        Exclusion Criteria:

          -  identical to those covered in HSC #2009-0055
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Karen E Hansen, M.D., M.S.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin-Madison, Department of Medicine, Division of Rheumatology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Wisconsin-Madison Hospital, Clinical Research Unit, Osteoporosis Research Center</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53705</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www2.medicine.wisc.edu/home/rheumatology/hansencurrentstudies</url>
    <description>Hansen Research Team website</description>
  </link>
  <reference>
    <citation>Hansen KE, Nabak AC, Johnson RE, Marvdashti S, Keuler NS, Shafer MM, Abrams SA. Isotope concentrations from 24-h urine and 3-h serum samples can be used to measure intestinal magnesium absorption in postmenopausal women. J Nutr. 2014 Apr;144(4):533-7. doi: 10.3945/jn.113.186767. Epub 2014 Feb 5.</citation>
    <PMID>24500940</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2012</study_first_submitted>
  <study_first_submitted_qc>May 7, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 8, 2012</study_first_posted>
  <last_update_submitted>October 31, 2016</last_update_submitted>
  <last_update_submitted_qc>October 31, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 1, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>vitamin D</keyword>
  <keyword>cholecalciferol</keyword>
  <keyword>bone mineral density</keyword>
  <keyword>Magnesium deficiency</keyword>
  <keyword>Calcium metabolism disorders</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Diseases</mesh_term>
    <mesh_term>Magnesium Deficiency</mesh_term>
    <mesh_term>Calcium Metabolism Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Vitamin D</mesh_term>
    <mesh_term>Ergocalciferols</mesh_term>
    <mesh_term>Cholecalciferol</mesh_term>
    <mesh_term>Calcium, Dietary</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

